{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T10:18:48Z","timestamp":1790072328286,"version":"4.0.1"},"reference-count":77,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["P30 MH085943"],"award-info":[{"award-number":["P30 MH085943"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Sanchez Foundation"},{"DOI":"10.13039\/100005632","name":"Forest","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005632","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","ajgponline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Geriatric Psychiatry"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.jagp.2015.12.003","type":"journal-article","created":{"date-parts":[[2016,1,15]],"date-time":"2016-01-15T04:28:25Z","timestamp":1452832105000},"page":"239-247","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"title":["Amyloid Hypothesis: Is There a Role for Antiamyloid Treatment in Late-Life Depression?"],"prefix":"10.1016","volume":"24","author":[{"given":"Nahla","family":"Mahgoub","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George S.","family":"Alexopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jagp.2015.12.003_bib0010","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0006-3223(02)01348-3","article-title":"Depression in Alzheimer's disease: overview and treatment","volume":"52","author":"Lyketsos","year":"2002","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.jagp.2015.12.003_bib0015","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1001\/archpsyc.63.5.530","article-title":"Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis","volume":"63","author":"Ownby","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.jagp.2015.12.003_bib0020","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/YCO.0b013e32834bb9d4","article-title":"Depression in dementia: epidemiology, mechanisms, and treatment","volume":"24","author":"Enache","year":"2011","journal-title":"Curr Opin Psychiatry"},{"key":"10.1016\/j.jagp.2015.12.003_bib0025","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1212\/WNL.0b013e3181e62124","article-title":"Recurrent depressive symptoms and the incidence of dementia and mild cognitive impairment","volume":"75","author":"Dotson","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.jagp.2015.12.003_bib0030","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1176\/appi.ajp.2007.07050744","article-title":"Microstructural white matter abnormalities and remission of geriatric depression","volume":"165","author":"Alexopoulos","year":"2008","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jagp.2015.12.003_bib0035","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jad.2011.12.002","article-title":"Functional connectivity in the cognitive control network and the default mode network in late-life depression","volume":"139","author":"Alexopoulos","year":"2012","journal-title":"J Affect Disord"},{"key":"10.1016\/j.jagp.2015.12.003_bib0040","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1176\/appi.ajp.159.11.1929","article-title":"Frontal white matter microstructure and treatment response of late-life depression: a preliminary study","volume":"159","author":"Alexopoulos","year":"2002","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jagp.2015.12.003_bib0045","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jad.2010.04.004","article-title":"MRI signal hyperintensities and treatment remission of geriatric depression","volume":"126","author":"Gunning-Dixon","year":"2010","journal-title":"J Affect Disord"},{"key":"10.1016\/j.jagp.2015.12.003_bib0050","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/gps.2290","article-title":"Anterior cingulate cortical volumes and treatment remission of geriatric depression","volume":"24","author":"Gunning","year":"2009","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.jagp.2015.12.003_bib0055","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1001\/archpsyc.1997.01830220033006","article-title":"\u201cVascular depression\u201d hypothesis","volume":"54","author":"Alexopoulos","year":"1997","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.jagp.2015.12.003_bib0060","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1176\/ajp.154.4.562","article-title":"Clinically defined vascular depression","volume":"154","author":"Alexopoulos","year":"1997","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jagp.2015.12.003_bib0065","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/mp.2013.20","article-title":"The vascular depression hypothesis: mechanisms linking vascular disease with depression","volume":"18","author":"Taylor","year":"2013","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.jagp.2015.12.003_bib0070","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1111\/j.1476-5381.2010.00669.x","article-title":"Soluble beta amyloid(1\u201342): a critical player in producing behavioural and biochemical changes evoking depressive-related state?","volume":"159","author":"Colaianna","year":"2010","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jagp.2015.12.003_bib0075","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/S0306-9877(02)00380-8","article-title":"Does increased platelet release of Abeta peptide contribute to brain abnormalities in individuals with depression?","volume":"60","author":"Pomara","year":"2003","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.jagp.2015.12.003_bib0080","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1007\/s00259-013-2627-0","article-title":"Increased brain amyloid deposition in patients with a lifetime history of major depression: evidenced on 18F-florbetapir (AV-45\/Amyvid) positron emission tomography","volume":"41","author":"Wu","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.jagp.2015.12.003_bib0085","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.mcna.2012.12.017","article-title":"Amyloid imaging with PET in early Alzheimer disease diagnosis","volume":"97","author":"Rowe","year":"2013","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.jagp.2015.12.003_bib0090","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1001\/archpsyc.63.2.161","article-title":"Increased hippocampal plaques and tangles in patients with Alzheimer disease with a lifetime history of major depression","volume":"63","author":"Rapp","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.jagp.2015.12.003_bib0095","first-page":"236re4","article-title":"An antidepressant decreases CSF Abeta production in healthy individuals and in transgenic AD mice","volume":"6","author":"Sheline","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jagp.2015.12.003_bib0100","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/S0140-6736(05)66665-2","article-title":"Depression in the elderly","volume":"365","author":"Alexopoulos","year":"2005","journal-title":"Lancet"},{"issue":"suppl 2","key":"10.1016\/j.jagp.2015.12.003_bib0105","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1017\/S1041610211000895","article-title":"Amyloid imaging","volume":"23","author":"Villemagne","year":"2011","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.jagp.2015.12.003_bib0110","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.bbadis.2011.11.005","article-title":"PET amyloid-beta imaging in preclinical Alzheimer's disease","volume":"1822","author":"Vlassenko","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jagp.2015.12.003_bib0115","doi-asserted-by":"crossref","first-page":"907","DOI":"10.3233\/JAD-142931","article-title":"Lifetime history of depression predicts increased amyloid-beta accumulation in patients with mild cognitive impairment","volume":"45","author":"Chung","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.jagp.2015.12.003_bib0120","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1192\/bjp.bp.110.078816","article-title":"Neuropathological correlates of late-life depression in older people","volume":"198","author":"Tsopelas","year":"2011","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.jagp.2015.12.003_bib0125","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.2174\/13816128113199990502","article-title":"Soluble amyloid-beta levels and late-life depression","volume":"20","author":"Osorio","year":"2014","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.jagp.2015.12.003_bib0130","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s11064-005-9029-z","article-title":"Elevation in plasma Abeta42 in geriatric depression: a pilot study","volume":"31","author":"Pomara","year":"2006","journal-title":"Neurochem Res"},{"key":"10.1016\/j.jagp.2015.12.003_bib0135","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/j.pnpbp.2011.05.013","article-title":"The correlation of plasma A\u03b242 levels, depressive symptoms, and cognitive function in the Korean elderly","volume":"35","author":"Moon","year":"2011","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.jagp.2015.12.003_bib0140","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/gps.1710","article-title":"Depression is associated with low plasma Abeta42 independently of cardiovascular disease in the homebound elderly","volume":"22","author":"Qiu","year":"2007","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.jagp.2015.12.003_bib0145","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/WAD.0b013e31819cb3ac","article-title":"Depression and plasma amyloid beta peptides in the elderly with and without the apolipoprotein E4 allele","volume":"23","author":"Sun","year":"2009","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.1016\/j.jagp.2015.12.003_bib0150","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1001\/archpsyc.65.5.542","article-title":"Amyloid-associated depression: a prodromal depression of Alzheimer disease?","volume":"65","author":"Sun","year":"2008","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.jagp.2015.12.003_bib0155","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1097\/JGP.0b013e3181df48be","article-title":"Plasma amyloid beta-42 independently predicts both late-onset depression and Alzheimer disease","volume":"18","author":"Blasko","year":"2010","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.jagp.2015.12.003_bib0160","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1093\/gerona\/gls093","article-title":"Plasma beta amyloid level and depression in older adults","volume":"68","author":"Metti","year":"2013","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.jagp.2015.12.003_bib0165","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.neurobiolaging.2011.09.004","article-title":"Blood-based biomarkers for Alzheimer's disease: plasma A\u03b240 and A\u03b242, and genetic variants","volume":"32","author":"Mayeux","year":"2011","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.jagp.2015.12.003_bib0170","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1001\/archneur.57.1.100","article-title":"Plasma and cerebrospinal fluid levels of amyloid beta proteins 1\u201340 and 1\u201342 in Alzheimer disease","volume":"57","author":"Mehta","year":"2000","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jagp.2015.12.003_bib0175","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000007917","article-title":"Cerebrospinal fluid levels of amyloid precursor protein and amyloid beta-peptide in Alzheimer's disease and major depression\u2014inverse correlation with dementia severity","volume":"39","author":"Hock","year":"1998","journal-title":"Eur Neurol"},{"key":"10.1016\/j.jagp.2015.12.003_bib0180","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1176\/appi.ajp.2011.11081153","article-title":"Lower CSF amyloid beta peptides and higher F2-isoprostanes in cognitively intact elderly individuals with major depressive disorder","volume":"169","author":"Pomara","year":"2012","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jagp.2015.12.003_bib0185","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1097\/JGP.0b013e3180547091","article-title":"The relationship between cerebrospinal fluid biomarkers and depression in elderly women","volume":"15","author":"Gudmundsson","year":"2007","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.jagp.2015.12.003_bib0190","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s007020070079","article-title":"CSF levels of tau, \u03b2-amyloid1\u201342 and GAP-43 in frontotemporal dementia, other types of dementia and normal aging","volume":"107","author":"Sj\u00f6gren","year":"2000","journal-title":"J Neural Transm (Vienna)"},{"key":"10.1016\/j.jagp.2015.12.003_bib0195","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1159\/000334644","article-title":"Cerebrospinal fluid Alzheimer markers in depressed elderly subjects with and without Alzheimer's disease","volume":"2","author":"Kramberger","year":"2012","journal-title":"Dement Geriatr Cogn Dis Extra"},{"key":"10.1016\/j.jagp.2015.12.003_bib0200","first-page":"S111","article-title":"Cerebral amyloid angiopathy and alzheimer's disease","volume":"61","author":"Ghiso","year":"2010","journal-title":"Hirosaki Igaku"},{"key":"10.1016\/j.jagp.2015.12.003_bib0205","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1093\/brain\/aws243","article-title":"Amyloid-beta-dependent compromise of microvascular structure and function in a model of Alzheimer's disease","volume":"135","author":"Dorr","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.jagp.2015.12.003_bib0210","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s12264-013-1422-z","article-title":"Apolipoprotein E, amyloid-beta, and neuroinflammation in Alzheimer's disease","volume":"30","author":"Dorey","year":"2014","journal-title":"Neurosci Bull"},{"key":"10.1016\/j.jagp.2015.12.003_bib0215","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/j.1476-5381.2010.00948.x","article-title":"Brain neurotoxic amyloid-beta peptides: their potential role in the pathophysiology of depression and as molecular therapeutic targets","volume":"161","author":"Pomara","year":"2010","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jagp.2015.12.003_bib0220","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1002\/gps.2672","article-title":"The inflammation hypothesis in geriatric depression","volume":"26","author":"Alexopoulos","year":"2011","journal-title":"Int J Geriatr Psychiatry"},{"issue":"Pt 3","key":"10.1016\/j.jagp.2015.12.003_bib0225","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1042\/bj2830633","article-title":"Human macrophages convert L-tryptophan into the neurotoxin quinolinic acid","volume":"283","author":"Heyes","year":"1992","journal-title":"Biochem J"},{"key":"10.1016\/j.jagp.2015.12.003_bib0230","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0167-5699(99)01520-0","article-title":"Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation?","volume":"20","author":"Mellor","year":"1999","journal-title":"Immunol Today"},{"key":"10.1016\/j.jagp.2015.12.003_bib0235","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.biopsych.2008.11.029","article-title":"Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression","volume":"65","author":"Miller","year":"2009","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.jagp.2015.12.003_bib0240","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1017\/S1461145709009924","article-title":"A potential role for pro-inflammatory cytokines in regulating synaptic plasticity in major depressive disorder","volume":"12","author":"Khairova","year":"2009","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.jagp.2015.12.003_bib0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1152\/physrev.1999.79.1.1","article-title":"Regulation of the hypothalamic-pituitary-adrenal axis by cytokines: actions and mechanisms of action","volume":"79","author":"Turnbull","year":"1999","journal-title":"Physiol Rev"},{"key":"10.1016\/j.jagp.2015.12.003_bib0250","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.psyneuen.2013.12.004","article-title":"HPA axis and aging in depression: systematic review and meta-analysis","volume":"41","author":"Belvederi Murri","year":"2014","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.jagp.2015.12.003_bib0255","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1465-9921-8-35","article-title":"Anti-inflammatory properties of desipramine and fluoxetine","volume":"8","author":"Roumestan","year":"2007","journal-title":"Respir Res"},{"key":"10.1016\/j.jagp.2015.12.003_bib0260","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1001\/2013.jamapsychiatry.4","article-title":"A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers","volume":"70","author":"Raison","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jagp.2015.12.003_bib0265","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1176\/appi.ajp.2014.14010094","article-title":"An inflammatory biomarker as a differential predictor of outcome of depression treatment with escitalopram and nortriptyline","volume":"171","author":"Uher","year":"2014","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jagp.2015.12.003_bib0270","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/2045-5380-1-11","article-title":"Frontostriatal functional connectivity in major depressive disorder","volume":"1","author":"Furman","year":"2011","journal-title":"Biol Mood Anxiety Disord"},{"key":"10.1016\/j.jagp.2015.12.003_bib0275","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.1093\/brain\/awu271","article-title":"Regional amyloid burden and intrinsic connectivity networks in cognitively normal elderly subjects","volume":"137","author":"Lim","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.jagp.2015.12.003_bib0280","doi-asserted-by":"crossref","first-page":"20","DOI":"10.4161\/pri.4.1.11378","article-title":"Fibril fragmentation in amyloid assembly and cytotoxicity: when size matters","volume":"4","author":"Xue","year":"2010","journal-title":"Prion"},{"key":"10.1016\/j.jagp.2015.12.003_bib0285","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1089\/brain.2014.0234","article-title":"Differences and the relationship in default mode network intrinsic activity and functional connectivity in mild Alzheimer's disease and amnestic mild cognitive impairment","volume":"4","author":"Weiler","year":"2014","journal-title":"Brain Connect"},{"key":"10.1016\/j.jagp.2015.12.003_bib0290","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.biopsych.2009.08.024","article-title":"Amyloid plaques disrupt resting state default mode network connectivity in cognitively normal elderly","volume":"67","author":"Sheline","year":"2010","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.jagp.2015.12.003_bib0295","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/nrd3505","article-title":"The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics","volume":"10","author":"Karran","year":"2011","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jagp.2015.12.003_bib0300","doi-asserted-by":"crossref","first-page":"120","DOI":"10.5607\/en.2010.19.3.120","article-title":"Drug development for Alzheimer's disease: recent progress","volume":"19","author":"Ji","year":"2010","journal-title":"Exp Neurobiol"},{"key":"10.1016\/j.jagp.2015.12.003_bib0305","doi-asserted-by":"crossref","first-page":"P139","DOI":"10.1016\/j.jalz.2013.04.083","article-title":"The novel BACE inhibitor MK-8931 dramatically lowers CSF beta-amyloid in patients with mild-to-moderate Alzheimer's disease","volume":"9","author":"Forman","year":"2013","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.jagp.2015.12.003_bib0310","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1124\/jpet.112.199356","article-title":"Pharmacodynamics of selective inhibition of gamma-secretase by avagacestat","volume":"344","author":"Albright","year":"2013","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jagp.2015.12.003_bib0315","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1111\/j.1476-5381.2008.00097.x","article-title":"CHF5074, a novel \u03b3-secretase modulator, attenuates brain \u03b2-amyloid pathology and learning deficit in a mouse model of Alzheimer's disease","volume":"156","author":"Imbimbo","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jagp.2015.12.003_bib0320","first-page":"121","article-title":"Drug evaluation: (R)-flurbiprofen\u2014an enantiomer of flurbiprofen for the treatment of Alzheimer's disease","volume":"10","author":"Geerts","year":"2007","journal-title":"IDrugs"},{"key":"10.1016\/j.jagp.2015.12.003_bib0325","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3233\/JAD-141959","article-title":"A phase II trial of tideglusib in Alzheimer's disease","volume":"45","author":"Lovestone","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.jagp.2015.12.003_bib0330","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1517\/14712598.2013.789856","article-title":"Bapineuzumab and solanezumab for Alzheimer's disease: is the \u201camyloid cascade hypothesis\u201d still alive?","volume":"13","author":"Tayeb","year":"2013","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.jagp.2015.12.003_bib0335","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1212\/01.WNL.0000159740.16984.3C","article-title":"Clinical effects of Abeta immunization (AN1792) in patients with AD in an interrupted trial","volume":"64","author":"Gilman","year":"2005","journal-title":"Neurology"},{"issue":"suppl 1","key":"10.1016\/j.jagp.2015.12.003_bib0340","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.1007\/s10875-014-0041-4","article-title":"Clinical trials of intravenous immunoglobulin for Alzheimer's disease","volume":"34","author":"Relkin","year":"2014","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jagp.2015.12.003_bib0345","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1056\/NEJMoa1304839","article-title":"Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease","volume":"370","author":"Salloway","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jagp.2015.12.003_bib0350","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1312889","article-title":"Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease","volume":"370","author":"Doody","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jagp.2015.12.003_bib0355","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3233\/JAD-2011-110977","article-title":"Gantenerumab: a novel human anti-A\u03b2 antibody demonstrates sustained cerebral amyloid-\u03b2 binding and elicits cell-mediated removal of human amyloid-\u03b2","volume":"28","author":"Bohrmann","year":"2011","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.jagp.2015.12.003_bib0360","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0891-0618(03)00046-2","article-title":"Effects of \u03b2-amyloid protein on serotoninergic, noradrenergic, and cholinergic markers in neurons of the pontomesencephalic tegmentum in the rat","volume":"26","author":"Gonzalo-Ruiz","year":"2003","journal-title":"J Chem Neuroanat"},{"key":"10.1016\/j.jagp.2015.12.003_bib0365","doi-asserted-by":"crossref","first-page":"4188","DOI":"10.1074\/jbc.271.8.4188","article-title":"Serotonin 5-HT2a and 5-HT2c receptors stimulate amyloid precursor protein ectodomain secretion","volume":"271","author":"Nitsch","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jagp.2015.12.003_bib0370","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0006-8993(02)03153-0","article-title":"Effect of a 5-HT(2C) serotonin agonist, dexnorfenfluramine, on amyloid precursor protein metabolism in guinea pigs","volume":"951","author":"Arjona","year":"2002","journal-title":"Brain Res"},{"key":"10.1016\/j.jagp.2015.12.003_bib0375","doi-asserted-by":"crossref","first-page":"14968","DOI":"10.1073\/pnas.1107411108","article-title":"Serotonin signaling is associated with lower amyloid-beta levels and plaques in transgenic mice and humans","volume":"108","author":"Cirrito","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jagp.2015.12.003_bib0380","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/gps.1763","article-title":"Possible therapeutic implication of Abeta disturbances in depression","volume":"22","author":"Pomara","year":"2007","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.jagp.2015.12.003_bib0385","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0006-3223(88)90038-8","article-title":"Cornell scale for depression in dementia","volume":"23","author":"Alexopoulos","year":"1988","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.jagp.2015.12.003_bib0390","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1586\/14737175.3.1.99","article-title":"Provisional diagnostic criteria for depression of Alzheimer's disease: description and review","volume":"3","author":"Olin","year":"2003","journal-title":"Expert Rev Neurother"}],"container-title":["The American Journal of Geriatric Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1064748115003152?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1064748115003152?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T20:30:12Z","timestamp":1718310612000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1064748115003152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":77,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S1064748115003152"],"URL":"https:\/\/doi.org\/10.1016\/j.jagp.2015.12.003","relation":{},"ISSN":["1064-7481"],"issn-type":[{"value":"1064-7481","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Amyloid Hypothesis: Is There a Role for Antiamyloid Treatment in Late-Life Depression?","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Geriatric Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jagp.2015.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 American Association for Geriatric Psychiatry. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}